1. Home
  2. IMCC vs MTEM Comparison

IMCC vs MTEM Comparison

Compare IMCC & MTEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCC
  • MTEM
  • Stock Information
  • Founded
  • IMCC 1980
  • MTEM N/A
  • Country
  • IMCC Israel
  • MTEM United States
  • Employees
  • IMCC N/A
  • MTEM N/A
  • Industry
  • IMCC Medicinal Chemicals and Botanical Products
  • MTEM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IMCC Health Care
  • MTEM Health Care
  • Exchange
  • IMCC Nasdaq
  • MTEM Nasdaq
  • Market Cap
  • IMCC 8.0M
  • MTEM 8.5M
  • IPO Year
  • IMCC N/A
  • MTEM N/A
  • Fundamental
  • Price
  • IMCC $2.32
  • MTEM $1.39
  • Analyst Decision
  • IMCC
  • MTEM
  • Analyst Count
  • IMCC 0
  • MTEM 0
  • Target Price
  • IMCC N/A
  • MTEM N/A
  • AVG Volume (30 Days)
  • IMCC 26.9K
  • MTEM 26.0K
  • Earning Date
  • IMCC 08-12-2024
  • MTEM 08-08-2024
  • Dividend Yield
  • IMCC N/A
  • MTEM N/A
  • EPS Growth
  • IMCC N/A
  • MTEM N/A
  • EPS
  • IMCC N/A
  • MTEM N/A
  • Revenue
  • IMCC $54,094,475.00
  • MTEM $31,763,000.00
  • Revenue This Year
  • IMCC $11.51
  • MTEM N/A
  • Revenue Next Year
  • IMCC $19.17
  • MTEM N/A
  • P/E Ratio
  • IMCC N/A
  • MTEM N/A
  • Revenue Growth
  • IMCC 12.87
  • MTEM N/A
  • 52 Week Low
  • IMCC $1.13
  • MTEM $1.01
  • 52 Week High
  • IMCC $8.10
  • MTEM $9.45
  • Technical
  • Relative Strength Index (RSI)
  • IMCC 40.79
  • MTEM 58.58
  • Support Level
  • IMCC $1.80
  • MTEM $1.21
  • Resistance Level
  • IMCC $2.98
  • MTEM $1.28
  • Average True Range (ATR)
  • IMCC 0.31
  • MTEM 0.10
  • MACD
  • IMCC 0.03
  • MTEM 0.03
  • Stochastic Oscillator
  • IMCC 44.11
  • MTEM 93.94

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

About MTEM Molecular Templates Inc.

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

Share on Social Networks: